CXCR4 and cancer: This ADC selectively eliminated CXCR4-overexpressing metastatic cells both in vitro and in vivo, achieving full inhibition of tumor growth in a lung-seeding cancer model, while causing a modest effect on non-target CXCR4+ hematopoietic cells at the bone marrow [235].